JOHNPHARMA

Johnson Pharmacare Ltd.

BSE: 532154

Sector: Services

Industry Group: Commercial Services & Supplies

Industry: Diversified Commercial Services

0.46+0.0 (+9.52%)

5 Oct, 3:30 PM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

Score not available

Value Score

Score not available

Price Momentum Score

Score not available

QVM Score

Score not available

Key Metrics

Market Cap

23.10

P/E (TTM)

P/B

53.08

P/S (TTM)

EV/EBITDA

CAPE (5Y)

ROE (TTM)

-196.93

ROCE (TTM)

-104.82

ROA (TTM)

-139.41

Avg 3Y ROE

-66.10

Earnings 3Y CAGR

-205.14

Sales 3Y CAGR

Sales 5Y CAGR

Debt/Equity

49.18

Consensus TP

Strong Buy %

Promoter Holding

Pledged %

Stock Analysis

Fundamental analysis overview of Johnson Pharmacare Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Not enough talking points with positive stance

Negative

Stock is fairly expensive with negative EPS on a trailing 12-month basis

Earnings yield of -245.81% indicates that the stock is very expensive and has a negative EPS on a trailing 12-month basis

What is Earnings yield (E/P)?

Low and declining ROE

The company reported low ROE of -196.92% for 12-month ended 30 Jun 2026 and ROE declined by -19588 bps from 1 year ago

What is ROE (FY)?

Low EPS growth and lower than median growth of industry

The company delivered moderate EPS growth of -9449.07% for 12-month ended 30 Jun 2026 and the growth was 9442.55 percentage points lower than median growth of industry

What is EPS growth (1Y)?

High and increasing Debt to Equity

The company has high Debt to Equity of 49.18 as on 30 Jun 2026 and Debt to Equity increased by 49.17 in the last 1 year

What is Debt to Equity?

Low dividend yield

The company has a low dividend yield of 0.0%

What is Dividend yield?

Neutral

Not enough talking points with neutral stance

Financial Snapshot

See detailed analysis

Multi-year trends for Johnson Pharmacare Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Johnson Pharmacare Ltd. Shareholding Pattern

Quarterly breakdown of Johnson Pharmacare Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Promoter	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Indian Promoter	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Foreign Promoter	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Institutions	-	-	-	-	-	-	-	-	-	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mutual Funds / UTI	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FI/Bank/Insurance	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Govt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Institutions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Non-Institution	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00
Bodies Corporate	83.30	83.43	83.43	78.97	79.00	82.00	77.03	67.57	21.66	18.82	14.62	11.92	11.86	11.86	11.86	11.86	11.86	11.86	11.86	11.86	11.86	11.86	11.86	11.86	11.86	11.86
Others (incl. Retail) No. of shareholders	16.70 563	16.57 569	16.57 558	21.03 415	21.00 458	18.00 690	22.97 893	32.43 7,604	78.34 88,364	81.18 1,05,410	85.38 1,12,300	88.08 1,18,311	88.14 1,16,883	88.14 1,16,877	88.14 1,16,871	88.14 1,16,877	88.14 1,16,832	88.14 1,16,807	88.14 1,17,303	88.14 1,17,007	88.14 1,17,011	88.14 1,17,004	88.14 1,17,007	88.14 1,17,007	88.14 1,17,007	88.14 1,17,007

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Johnson Pharmacare Ltd. shares as reported to NSE and BSE.

Name	Date	Type	Price	Qty.	Value
Topgain Finance Private Limited	05 Jul 2024	sell	₹ 1.20	54.95 lac	₹ 65.94 lac
Topgain Finance Private Limited	05 Jul 2024	buy	₹ 1.19	3.00 lac	₹ 3.57 lac
Multiplier Share & Stock Advisors Private Limited	05 Jul 2024	sell	₹ 1.19	67.77 lac	₹ 80.65 lac
Multiplier Share & Stock Advisors Private Limited	04 Jul 2024	sell	₹ 1.15	38.46 k	₹ 44.23 k
Multiplier Share & Stock Advisors Private Limited	04 Jul 2024	buy	₹ 1.15	27.77 lac	₹ 31.94 lac
Topgain Finance Private Limited	27 Jun 2024	buy	₹ 0.95	50.37 lac	₹ 47.85 lac
Multiplier Share & Stock Advisors Private Limited	27 Jun 2024	sell	₹ 0.95	45.86 lac	₹ 43.56 lac
Topgain Finance Private Limited	19 Jan 2024	sell	₹ 0.98	30.00 lac	₹ 29.40 lac
Topgain Finance Private Limited	18 Jan 2024	sell	₹ 1.02	5.45 lac	₹ 5.56 lac
Topgain Finance Private Limited	18 Jan 2024	buy	₹ 1.00	30.00 lac	₹ 30.00 lac

…

Corporate Actions

History of Johnson Pharmacare Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Bonus1 new shares for 10 existing shares
Ex-date: 7th Apr 2022Announced on: 24th Mar 2022
Stock Split1 : 10
Ex-date: 5th Jan 2022Announced on: 7th Oct 2021
Nominal value changes from INR 10 to INR 1

Company Profile

Overview of Johnson Pharmacare Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Johnson Pharmacare Limited is an India-based company. The Company is not engaged in any business activities. It has not generated any revenues.

Key personnel

Hiteshkumar Manharbhai PatelD

Executive & Non Independent Chairman of the Board, Compliance Officer

Mr. Ramanlal Nagjibhai TrivediD

Chief Financial Officer, Whole Time Director

Mr. Dheeraj KumarD

Additional Executive Director

Mr. Chetanbhai Rajeshbhai ParmarD

Additional Director

Mr. Rajeshbhai Babubhai ParmarD

Additional Director

Mr. Kshitish PatelD

Non-Executive Director

Mr. Nand Kishore RayD

Additional Non-Executive and Non-Independent Director

Ms. Aishwarya Gopalbhai ModiD

Independent Director

View all

Incorporated on

30 Jun 1994

Last Annual

31 Mar 2026

Last Interim

30 Jun 2026

No. of Employees

IPO date

18 Jul 2005

Free Float

51,90,51,205

Website

http://www.johnsonpharmacareltd.shop/

Phone no.

Address

6Th Floor, A-Wing/Part-Iii, B. D. Patel House,, Naranpura Road, Naranpura,, AHMEDABAD, 380014, India

Frequently Asked Questions

What is the current share price of Johnson Pharmacare Ltd.?

The current share price of Johnson Pharmacare Ltd. is ₹ 0.46 as of 5 Oct 2026.

What is the market capitalisation of Johnson Pharmacare Ltd.?

The market capitalisation of Johnson Pharmacare Ltd. stands at ₹ 23.10 Cr.

What is the PE ratio of Johnson Pharmacare Ltd.?

The Price-to-Earnings (PE) ratio of Johnson Pharmacare Ltd. is - as of the latest trailing twelve months data.

What is the ROE and ROCE of Johnson Pharmacare Ltd.?

Johnson Pharmacare Ltd. has a Return on Equity (ROE) of -196.93% and a Return on Capital Employed (ROCE) of -104.82% as per the latest financial reports.

What is the 52-week high and low of Johnson Pharmacare Ltd.?

The 52-week high of Johnson Pharmacare Ltd. is - and the 52-week low is -.

What is the dividend yield of Johnson Pharmacare Ltd.?

The dividend yield of Johnson Pharmacare Ltd. is 0.00% based on the current market price.

What is the FII and DII holding in Johnson Pharmacare Ltd.?

Foreign Institutional Investors (FII) hold 0.00%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 88.14% of Johnson Pharmacare Ltd. shares.

What sector does Johnson Pharmacare Ltd. belong to?

Johnson Pharmacare Ltd. operates in the Services sector.

What is the beta of Johnson Pharmacare Ltd.?

The beta of Johnson Pharmacare Ltd. is 0.69, indicating its price volatility relative to the broader market. Over the past 1 year, Johnson Pharmacare Ltd. has delivered an absolute return of -45.45%.

What is the RSI of Johnson Pharmacare Ltd.?

The 14-day Relative Strength Index (RSI) of Johnson Pharmacare Ltd. is 31.15, placing it approaching oversold territory. An RSI above 70 is considered overbought and below 30 is considered oversold.

Johnson Pharmacare Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Johnson Pharmacare Ltd. Shareholding Pattern

Bulk, Block and Insider Trades

Corporate Actions

Company Profile

Frequently Asked Questions

Stock Analysis

Corporate Actions

Company Profile